Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension

Author(s):  Allen Loyd V Jr

Issue:  Mar/Apr 2021 - Volume 25, Number 2
View All Articles in Issue

Page(s):  144

Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, eslicarbazepine acetate, formulation, anticonvulsant agent, seizure disorders, partial-onset seizures, children, adolescents

Related Categories: EXCIPIENTS, FORMULATIONS, PEDIATRICS, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Allen Loyd V Jr
Mar/Apr 2021
Pg. 144

Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 502

Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions
Allen Loyd V Jr
Nov/Dec 2018
Pg. 496

Minoxidil 1-mg/mL in Ora-Plus and Ora-Sweet SF Suspension
Allen Loyd V Jr
Jan/Feb 2019
Pg. 57

Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF
Allen Loyd V Jr
Jul/Aug 2020
Pg. 316

Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
Jan/Feb 2022
Pg. 56

Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
Jan/Feb 2018
Pg. 58

Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
Jan/Feb 2018
Pg. 51

Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
May/Jun 2022
Pg. 241

Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
Jan/Feb 2023
Pg. 53

Venlafaxine 15 mg/mL in Ora-Plus:Ora-Sweet (1:1) Suspension
Allen Loyd V Jr
May/Jun 2020
Pg. 233

Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension
Allen Loyd V Jr
Sep/Oct 2018
Pg. 411

Pyrimethamine 2 mg/mL in Ora-Plus and Ora-Sweet Oral Suspension
Allen Loyd V Jr
May/Jun 2018
Pg. 236

Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
Sep/Oct 2019
Pg. 413

Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
Jan/Feb 2023
Pg. 51

Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
Jan/Feb 2023
Pg. 52

Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
Nov/Dec 2022
Pg. 513

Glycopyrrolate 0.2 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
Mar/Apr 2020
Pg. 132

Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet
Allen Loyd V Jr
May/Jun 2019
Pg. 236

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Return to Top